Ove Alexander Høgmoen Åstrand

Author

Also Known As

Astrand, O.A.H., O. Alexander H. Åstrand, Ove Alexander Høgmoen Åstrand, Åstrand, O.A.H., Åstrand, Ove Alexander Høgmoen

Publications

275

Citations

H-Index

Concepts

All Affiliations

University of Oslo UiT The Arctic University of Norway University Hospital of North Norway Centre Léon Bérard Université Claude Bernard Lyon 1

About

Ove Alexander Høgmoen Åstrand is an author at University of Oslo specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	107
2	Natural Sciences	5	5	92
3	Biochemistry	5	5	92
4	Engineering	1	1	15
5	Biomolecular Engineering	1	1	15

Ove Alexander Høgmoen Åstrand

Publications

232

Citations

H-Index

Page 1

	Year	Citations
Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors Christian Schnaars, Geir Kildahl‐Andersen, Anthony Prandina, ACS Infectious Diseases	2018	44
Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives Elvar Örn Viktorsson, Bendik Melling Grøthe, Reidun Aesöy, Bioorganic & Medicinal Chemistry Medicinal ChemistryAntileukemic EvaluationsBioorganic ChemistryPharmaceutical ScienceBiochemistry	2017	30
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens <i>In Vivo</i> Ørjan Samuelsen, Ove Alexander Høgmoen Åstrand, Christopher Fröhlich, Antimicrobial Agents and Chemotherapy	2020	30
Antimicrobial Activity and Cytotoxicity of Ag(I) and Au(I) Pillarplexes Alexander Pöthig, Sara Ahmed, Hanne C. Winther‐Larsen, Frontiers in Chemistry	2018	27
Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity Robert L. Smith, Ove Alexander Høgmoen Åstrand, Luan Nguyen, Bioorganic & Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceCell-specific ToxicityBiochemistryMedicine	2014	20
Synthesis and biological evaluation of new dipicolylamine zinc chelators as metallo-β-lactamase inhibitors Anthony Prandina, Sylvie Radix, Marc Le Borgne, Tetrahedron Medicinal ChemistryBiochemistryNatural SciencesMedicineMetalloprotein	2019	16
Degradative Behavior and Toxicity of Alkylated Imidazoles Sigvart Evjen, Ove Alexander Høgmoen Åstrand, Mona Gaarder, Industrial & Engineering Chemistry Research High Thermal StabilityEngineeringMedicineCo2 Rich EnvironmentDegradation Reaction	2019	15
Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors Geir Kildahl‐Andersen, Christian Schnaars, Anthony Prandina, MedChemComm Zinc Chelator StrengthMetallo-β-lactamase InhibitorsPeptide ScienceAntimicrobial ChemotherapyAnalytical Ultracentrifugation	2019	14
Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases Fatema Rahman, Imin Wushur, Nabin Malla, Molecules	2021	14
Synthesis and initial in vitro biological evaluation of two new zinc-chelating compounds: Comparison with TPEN and PAC-1 Ove Alexander Høgmoen Åstrand, Gulzeb Aziz, Sidra Farzand Ali, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesBioactive Metal	2013	12

Page 1